Back to top
more

First Trust NYSE Arca Biotechnology ETF: (FBT)

(Delayed Data from NYSE) As of Jun 9, 2026 10:37 AM ET

$225.07 USD

225.065
7,167

+3.92 (1.77%)

Volume: 7,167

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

Zacks News

Sanghamitra Saha headshot

4 Sector ETFs That Crushed S&P 500 in Longest Bull Market

These sector ETFs outperformed the S&P 500 in the longest-ever bull market.

    Sweta Killa headshot

    Market-Beating, Top-Ranked ETFs of the Longest Bull Market

    The U.S. bull market is now the longest ever, stretching 3,453 days or nine and-a-half years. We have presented a bunch of top performing ETFs of the longest bull market.

      Sanghamitra Saha headshot

      Biotech ETFs in Focus on String of Q2 Earnings Beat

      Biotech ETFs draw attention post impressive Q2 results.

        Neena Mishra headshot

        What Investors Need to Know about Biotech ETFs

        Smaller biotech stocks are outperforming this year; learn more about biotech ETFs best positioned to benefit

          Sweta Killa headshot

          5 Safe and Sound ETF Strategies for 2H

          After a bumpy ride in the first half of the year, global stocks are bouncing back despite the trade war fears.

            Sweta Killa headshot

            Biotech ETFs Surge on Biogen's Positive Drug Trial Result

            Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment.

              Sweta Killa headshot

              4 Hot Sector ETFs Springing Up to Rank #1

              A number of funds in their respective sectors have seen their Ranks surging to the top hierarchy and could make great spring picks.

                Sweta Killa headshot

                M&A Waves Pushing Biotech ETFs Higher

                The new tax legislation has enticed U.S. companies to bring offshore cash back home, sparking waves of mergers and acquisitions.

                  Zacks Equity Research

                  Biotech ETFs: What Lies Ahead?

                  It's been a good year for biotech ETFs, can the rally continue?

                    Zacks Equity Research

                    The Zacks Analyst Blog Highlights: SPDR Technology ETF, SPDR S&P Biotech ETF, First Trust NYSE Arca Biotechnology Index Fund, BioShares Biotechnology Products ETF and SPDR Healthcare ETF

                    The Zacks Analyst Blog Highlights: SPDR Technology ETF, SPDR S&P Biotech ETF, First Trust NYSE Arca Biotechnology Index Fund, BioShares Biotechnology Products ETF and SPDR Healthcare ETF